Company intelligence / Profile preview

Angel Lane Principal Strategies

Ownership: Private
Development stage: Other

Overview

Angel Lane Principal Strategies appears to have been an investment management or hedge fund entity rather than an operating biotechnology, pharmaceutical, or healthcare company. Publicly available references primarily identify it as a former employer of healthcare investor Brigette Roberts, alongside other hedge funds and investment firms. I could not find evidence that Angel Lane Principal Strategies developed therapeutics, operated a clinical pipeline, or provided life sciences products or services. Based on the available information, it is best characterized as a financial investment organization with some historical connection to healthcare investing, not as a biotech or healthcare operating company.

Industry: Investors

Beyond the preview

Go deeper on Angel Lane Principal Strategies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Angel Lane Principal Strategies.

Explore the full profile